MNPR early signalMNPR is @0.80 right now. Volume is an alpha, even though it looks like nothing, but it is coming in. Price is for sure showing optimism. Let's see what it brings.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.15 EUR
−7.61 M EUR
0.00 EUR
2.01 M
About Monopar Therapeutics Inc.
Sector
Industry
CEO
Chandler Drew Robinson
Website
Headquarters
Wilmette
Founded
2014
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1IY0 is 15.60 EUR — it has increased by 7.59% in the past 24 hours. Watch MONOPAR THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MONOPAR THERAPEUTICS INC stocks are traded under the ticker 1IY0.
1IY0 stock has risen by 227.73% compared to the previous week, the month change is a 227.73% rise, over the last year MONOPAR THERAPEUTICS INC has showed a 656.36% increase.
We've gathered analysts' opinions on MONOPAR THERAPEUTICS INC future price: according to them, 1IY0 price has a max estimate of 46.23 EUR and a min estimate of 8.32 EUR. Watch 1IY0 chart and read a more detailed MONOPAR THERAPEUTICS INC stock forecast: see what analysts think of MONOPAR THERAPEUTICS INC and suggest that you do with its stocks.
1IY0 reached its all-time high on Sep 30, 2024 with the price of 6.35 EUR, and its all-time low was 2.01 EUR and was reached on Aug 29, 2024. View more price dynamics on 1IY0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1IY0 stock is 7.33% volatile and has beta coefficient of 2.15. Track MONOPAR THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is MONOPAR THERAPEUTICS INC there?
Yes, you can track MONOPAR THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
MONOPAR THERAPEUTICS INC is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
1IY0 earnings for the last quarter are −0.47 EUR per share, whereas the estimation was −0.47 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are −1.37 EUR per share. See more details about MONOPAR THERAPEUTICS INC earnings.
MONOPAR THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1IY0 net income for the last quarter is −1.60 M EUR, while the quarter before that showed −1.52 M EUR of net income which accounts for −5.28% change. Track more MONOPAR THERAPEUTICS INC financial stats to get the full picture.
No, 1IY0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 10.00 employees. See our rating of the largest employees — is MONOPAR THERAPEUTICS INC on this list?
Like other stocks, 1IY0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MONOPAR THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.